Transplantation and Cellular Therapy

Published by: Elsevier Inc.  

People

  1. Park
    Park
  2. Perales
    Perales
  3. Giralt
    Giralt
  4. Dahi
    Dahi
  5. Lin
    Lin
  6. Palomba
    Palomba
  7. Scordo
    Scordo
  8. Shah
    Shah
  9. Shouval
    Shouval
  10. Devlin
    Devlin

Groups

  1. Adult Leukemia (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. Hematologic Malignancies, Division of (15)
  5. Bone Marrow Transplant (11)
  6. Graduate Medical Education (8)
  7. Biostatistics Service (7)
  8. CTCR Scholars (7)
  9. Epidemiology and Biostatistics (7)
  10. MSK Grad Students (7)
Search Within
  1. "Adult Leukemia"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
  3. Review (2)
  4. Editorial (1)
  5. Guidelines (1)
Groups
  1. Adult Leukemia (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. Hematologic Malignancies, Division of (15)
  5. Bone Marrow Transplant (11)
  6. Graduate Medical Education (8)

More Groups

People
  1. Jae Park (9)
  2. Miguel-Angel Perales (9)
  3. Sergio Giralt (8)
  4. Parastoo Dahi (6)
  5. Sean Devlin (6)
  6. Gunjan Shah (5)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (4)
  5. 2021 (5)
Publishers
  1. Elsevier Inc. (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
    Meeting Abstract

    Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort
    Journal Article

    Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Cautionary tale of unopposed prophylactic il6 receptor blockade in axicabtagene ciloleucel for large B-cell lymphoma
    Editorial

    Valtis, Y. K.; Park, J. H.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Subsequent malignancies after CD19-targeted chimeric antigen receptor T cells in patients with lymphoma
    Journal Article

    Lorenc, R.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Saldia, A.; Luna De Abia, A.; De Lapuerta, M. C.; Tomas, A. A.; Cassanello, G.; Leslie, L. A.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era
    Meeting Abstract

    Vaughn, J. L.; Devlin, S. M.; Berman, E.; Mauro, M. J.; Papadopoulos, E. B.; Perales, M. A.; Tallman, M.; Giralt, S. A.; Gyurkocza, B.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcomes of CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory B cell acute lymphoblastic leukemia
    Journal Article

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Perica, K.; Park, J. H.; Forlenza, C. J.; Shukla, N. N.; Steinherz, P. G.; Margossian, S. P.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save

    • Transplantation and Cellular Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 Unknown
    Transplantation and Cellular Therapy 26666375 Unknown
    Transplantation and Cellular Therapy 2666-6375 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2020
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666375 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2021
    Transplantation and Cellular Therapy 26666375 2024
    Transplantation and Cellular Therapy 26666375 Elsevier B.V.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2023
    Transplantation and Cellular Therapy 26666375 The Authors
    Transplantation and Cellular Therapy 26666367 2022
    Transplantation and Cellular Therapy 26666367 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2024
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Unknown (26666375) 26666375 Elsevier B.V.